Are you above the legal age to view this content in your province/state?

Home / Cannabis Industry / Slumping sales in medical marijuana

Slumping sales in medical marijuana

Regulations have been strict in Hawaii, hampering the growth of the state’s medical marijuana industry, causing sales to slow and making the regulated market uncompetitive with the illicit market, according to new data.

The analysis, commissioned by the Hawaii Cannabis Industry Association, found that sales have slowed from an annual growth of 110% in 2019 to 68% in 2020 to only 12% in 2021, Honolulu-based media outlet Hawaii News Now reported.

The report also shows that only four of 10 patients have purchased medical marijuana from the licensed market. That leaves more than 20,000 registered patients who are not purchasing cannabis from legal dispensaries.

The industry cites overly stringent taxes and a complicated medical ID-verification process for patients as two of several problems with the regulatory structure set by the state.

“These regulatory policies not only hinder growth of the legal medical cannabis industry, they impair the legal industry’s intended displacement of illegal cannabis sales,” according to the report, which was written by economist Paul Brewbaker.

The industry association recommends that the state:

Increase the number of allowed medical marijuana dispensaries per business in order to expand geographic access.

Increase the amount of allowed cultivation production per licensee to meet demand.

Allow a wholesale market where MMJ companies can sell to each other.

“In its current form, the medical cannabis industry is unsustainable and will continue to decline without substantive regulatory and statutory changes,” the report concludes.



Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.

Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.

Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.

Investment Value Finders is intended for those 21+ years of age only!

Check Also

Cannabis producer Canopy Growth sheds 8% of workforce

Canadian cannabis producer Canopy Growth slashed approximately 8% of its workforce Tuesday as part of …